SG10201913164YA - Humanized light chain mice - Google Patents

Humanized light chain mice

Info

Publication number: SG10201913164YA
Authority: SG; Singapore
Prior art keywords: light chain; humanized light; chain mice; mice; humanized
Prior art date: 2011-12-20

Application number

SG10201913164YA

Other languages

English (en)

Inventor

Lynn Macdonald

Cagan Gurer

Karolina Hosiawa

Sean Stevens

Andrew Murphy

Original Assignee

Regeneron Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-12-20

Filing date

2012-12-17

Publication date

2020-03-30

2012-12-17 Application filed by Regeneron Pharma filed Critical Regeneron Pharma

2020-03-30 Publication of SG10201913164YA publication Critical patent/SG10201913164YA/en

Classifications

- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
- C07K16/462—Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/20—Pseudochromosomes, minichrosomosomes
- C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Environmental Sciences (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Animal Husbandry (AREA)
Biodiversity & Conservation Biology (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pyrane Compounds (AREA)

SG10201913164YA 2011-12-20 2012-12-17 Humanized light chain mice SG10201913164YA (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201161578097P	2011-12-20	2011-12-20

Publications (1)

Publication Number	Publication Date
SG10201913164YA true SG10201913164YA (en)	2020-03-30

Family

ID=47501484

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
SG10201605675WA SG10201605675WA (en)	2011-12-20	2012-12-17	Humanized light chain mice
SG11201403326VA SG11201403326VA (en)	2011-12-20	2012-12-17	Humanized light chain mice
SG10201913164YA SG10201913164YA (en)	2011-12-20	2012-12-17	Humanized light chain mice

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
SG10201605675WA SG10201605675WA (en)	2011-12-20	2012-12-17	Humanized light chain mice
SG11201403326VA SG11201403326VA (en)	2011-12-20	2012-12-17	Humanized light chain mice

Country Status (28)

Country	Link
US (6)	US9706759B2 (pl)
EP (2)	EP2793567B1 (pl)
JP (6)	JP6327750B2 (pl)
KR (5)	KR102186822B1 (pl)
CN (1)	CN104159444B (pl)
AU (6)	AU2012323987B2 (pl)
BR (2)	BR122021007339B1 (pl)
CA (1)	CA2859408C (pl)
CY (1)	CY1121638T1 (pl)
DK (1)	DK2793567T3 (pl)
ES (1)	ES2720186T3 (pl)
HR (1)	HRP20190897T1 (pl)
HU (1)	HUE044266T2 (pl)
IL (3)	IL233153B (pl)
IN (1)	IN2014DN06094A (pl)
LT (1)	LT2793567T (pl)
ME (1)	ME03477B (pl)
MX (3)	MX356429B (pl)
MY (1)	MY173936A (pl)
PL (1)	PL2793567T3 (pl)
PT (1)	PT2793567T (pl)
RS (1)	RS58761B1 (pl)
RU (2)	RU2664181C2 (pl)
SG (3)	SG10201605675WA (pl)
SI (1)	SI2793567T1 (pl)
SM (1)	SMT201900296T1 (pl)
TR (1)	TR201903439T4 (pl)
WO (1)	WO2013096142A1 (pl)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9445581B2 (en)	2012-03-28	2016-09-20	Kymab Limited	Animal models and therapeutic molecules
NZ597481A (en)	2009-07-08	2013-10-25	Kymab Ltd	Animal models and therapeutic molecules
US10662256B2 (en)	2010-07-26	2020-05-26	Trianni, Inc.	Transgenic mammals and methods of use thereof
EP2597945B1 (en)	2010-07-26	2020-07-22	Trianni, Inc.	Transgenic animals and methods of use
MY172618A (en)	2010-08-02	2019-12-06	Regeneron Pharma	Mice that make binding proteins comprising vl domains
SI4067496T1 (sl)	2011-02-25	2023-07-31	Regeneron Pharmaceuticals, Inc.	Miši ADAM6
SG10201606158TA (en)	2011-08-05	2016-09-29	Regeneron Pharma	Humanized universal light chain mice
EP2758534B1 (en)	2011-09-19	2020-04-29	Kymab Limited	Animals, repertoires & methods for the production of human antibodies
CN107056936B (zh)	2011-09-19	2021-09-03	科马布有限公司	免疫球蛋白基因多样性的操纵及多抗体治疗剂
EP2761008A1 (en)	2011-09-26	2014-08-06	Kymab Limited	Chimaeric surrogate light chains (slc) comprising human vpreb
US10246509B2 (en) *	2011-10-17	2019-04-02	Regeneron Pharmaceuticals, Inc.	Restricted immunoglobulin heavy chain mice
US20180295821A1 (en) *	2011-12-02	2018-10-18	Kymab Limited	Transgenic Animals
GB201122047D0 (en) *	2011-12-21	2012-02-01	Kymab Ltd	Transgenic animals
US9253965B2 (en)	2012-03-28	2016-02-09	Kymab Limited	Animal models and therapeutic molecules
RU2664181C2 (ru)	2011-12-20	2018-08-15	Регенерон Фармасьютикалз, Инк.	Мыши с гуманизированной легкой цепью
RU2770016C2 (ru) *	2012-02-01	2022-04-14	Регенерон Фармасьютикалз, Инк.	Гуманизированные грызуны, которые экспрессируют тяжелые цепи, содержащие домены vl
US10251377B2 (en)	2012-03-28	2019-04-09	Kymab Limited	Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
GB2502127A (en)	2012-05-17	2013-11-20	Kymab Ltd	Multivalent antibodies and in vivo methods for their production
NZ703689A (en)	2012-06-12	2016-05-27	Regeneron Pharma	Humanized non-human animals with restricted immunoglobulin heavy chain loci
PL2840892T3 (pl)	2013-02-20	2018-09-28	Regeneron Pharmaceuticals, Inc.	Zwierzęta niebędące człowiekiem ze zmodyfikowanymi sekwencjami łańcucha ciężkiego immunoglobuliny
US9788534B2 (en)	2013-03-18	2017-10-17	Kymab Limited	Animal models and therapeutic molecules
US9783618B2 (en)	2013-05-01	2017-10-10	Kymab Limited	Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
US9783593B2 (en)	2013-05-02	2017-10-10	Kymab Limited	Antibodies, variable domains and chains tailored for human use
US11707056B2 (en)	2013-05-02	2023-07-25	Kymab Limited	Animals, repertoires and methods
AU2014330922A1 (en)	2013-10-01	2016-03-03	Kymab Limited	Animal models and therapeutic molecules
AU2015230938C1 (en)	2014-03-21	2021-10-14	Regeneron Pharmaceuticals, Inc.	Non-human animals that make single domain binding proteins
RU2016141123A (ru)	2014-03-21	2018-04-23	Регенерон Фармасьютикалз, Инк.	Антигенсвязывающие белки vl, проявляющие различные связывающие характеристики
US11111314B2 (en)	2015-03-19	2021-09-07	Regeneron Pharmaceuticals, Inc.	Non-human animals that select for light chain variable regions that bind antigen
WO2017035252A1 (en) *	2015-08-24	2017-03-02	Trianni, Inc.	Enhanced production of immunoglobulins
US10813346B2 (en)	2015-12-03	2020-10-27	Trianni, Inc.	Enhanced immunoglobulin diversity
ES2977547T3 (es)	2016-05-20	2024-08-26	Regeneron Pharma	Métodos para romper la tolerancia inmunológica utilizando múltiples ARN guía
WO2017214089A1 (en) *	2016-06-06	2017-12-14	Regeneron Pharmaceuticals, Inc.	Non-human animals expressing antibodies with human lambda light chains
LT3766343T (lt) *	2016-11-04	2022-06-10	Regeneron Pharmaceuticals, Inc.	Gyvūnai, išskyrus žmogų, turintys sukonstruotą imunoglobulino lambda lengvosios grandinės lokusą
KR102777514B1 (ko)	2017-01-19	2025-03-06	옴니에이비 오퍼레이션스, 인코포레이티드	다중 중쇄 면역글로불린 유전자좌를 갖는 트랜스제닉 설치류 기원의 인간 항체
NZ760232A (en)	2017-06-07	2023-05-26	Regeneron Pharma	Compositions and methods for internalizing enzymes
FI4140297T3 (fi) *	2017-12-05	2025-07-10	Regeneron Pharma	Muokatun immunoglobuliinin lambda-kevytketjun hiiriä ja niiden käyttöjä
SG11202007363TA (en)	2018-02-07	2020-08-28	Regeneron Pharma	Methods and compositions for therapeutic protein delivery
HUE070158T2 (hu) *	2018-03-24	2025-05-28	Regeneron Pharma	Genetikailag módosított egerek vagy patkányok peptid-mhc komplexek elleni terápiás antitestek létrehozásra, ezek elõállítására szolgáló módszerek, valamint alkalmazásuk
MX2020012350A (es)	2018-05-17	2021-01-29	Regeneron Pharma	Anticuerpos anti-cd63, conjugados y usos de estos.
CN109359045B (zh) *	2018-10-16	2022-01-04	武汉斗鱼网络科技有限公司	一种测试方法、装置、设备和存储介质
JP2020146297A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146299A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146317A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146298A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146316A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146301A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146303A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146306A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146308A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146314A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146305A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146311A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146307A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146318A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146300A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146304A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146309A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146302A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146315A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146310A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
JP2020146313A (ja) *	2019-03-14	2020-09-17	株式会社三洋物産	遊技機
KR20220016880A (ko) *	2019-06-05	2022-02-10	리제너론 파마슈티칼스 인코포레이티드	카파 유전자좌에서 발현된 제한적 람다 경쇄 레퍼토리를 갖는 비-인간 동물 및 이의 용도
KR20220025839A (ko) *	2019-07-01	2022-03-03	트리아니, 인코포레이티드	유전자이식 포유동물 및 이의 사용 방법
DK3785536T3 (da) *	2019-08-28	2022-03-28	Trianni Inc	Adam6-knockin-mus
EP4179095A4 (en) *	2020-07-13	2024-08-21	Kisoji Biotechnology Inc.	TRANSGENIC ANIMALS EXPRESSING HEAVY CHAIN ANTIBODIES
CA3187680A1 (en)	2020-09-11	2022-03-17	Yashu Liu	Identification and production of antigen-specific antibodies
WO2022071161A1 (ja)	2020-10-02	2022-04-07	日亜化学工業株式会社	光源装置及び導光アレイ部
KR20230147048A (ko)	2020-12-16	2023-10-20	리제너론 파마슈티칼스 인코포레이티드	인간화 Fc 알파 수용체를 발현하는 마우스
US11926661B2 (en)	2021-04-20	2024-03-12	Regeneron Pharmaceuticals, Inc.	Human antibodies to artemin and methods of use thereof
MA71452A (fr)	2022-07-12	2025-04-30	Regeneron Pharmaceuticals, Inc.	Anticorps dirigés contre le récepteur du facteur neurotrophique ciliaire (cntfr) et leurs procédés d'utilisation
WO2024173248A1 (en)	2023-02-13	2024-08-22	Regeneron Pharmaceuticals, Inc.	Treatment of muscle related disorders with anti-human cacng1 antibodies
WO2024229105A1 (en)	2023-05-02	2024-11-07	Regeneron Pharmaceuticals, Inc.	Anti-human m-cadherin (cdh15) antibodies, conjugates, and uses thereof for delivery of genetic payloads to muscle cells
WO2025014533A1 (en)	2023-07-10	2025-01-16	Regeneron Pharmaceuticals, Inc.	Anti-human cacng1 antibody-drug conjugates and uses thereof

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8823869D0 (en)	1988-10-12	1988-11-16	Medical Res Council	Production of antibodies
WO1991000906A1 (en)	1989-07-12	1991-01-24	Genetics Institute, Inc.	Chimeric and transgenic animals capable of producing human antibodies
US6673986B1 (en)	1990-01-12	2004-01-06	Abgenix, Inc.	Generation of xenogeneic antibodies
US6657103B1 (en)	1990-01-12	2003-12-02	Abgenix, Inc.	Human antibodies derived from immunized xenomice
US5545806A (en)	1990-08-29	1996-08-13	Genpharm International, Inc.	Ransgenic non-human animals for producing heterologous antibodies
US7041871B1 (en) *	1995-10-10	2006-05-09	Genpharm International, Inc.	Transgenic non-human animals capable of producing heterologous antibodies
US5770429A (en)	1990-08-29	1998-06-23	Genpharm International, Inc.	Transgenic non-human animals capable of producing heterologous antibodies
ATE414768T1 (de)	1991-04-10	2008-12-15	Scripps Research Inst	Bibliotheken heterodimerer rezeptoren mittels phagemiden
AU669124B2 (en)	1991-09-18	1996-05-30	Kyowa Hakko Kirin Co., Ltd.	Process for producing humanized chimera antibody
EP0746609A4 (en) *	1991-12-17	1997-12-17	Genpharm Int	NON-HUMAN TRANSGENIC ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES
FI952658A0 (fi)	1992-12-01	1995-05-31	Protein Design Labs Inc	L-selektiinin kanssa reaktiivisia humanisoituja vasta-aineita
US5523226A (en) *	1993-05-14	1996-06-04	Biotechnology Research And Development Corp.	Transgenic swine compositions and methods
US6632976B1 (en)	1995-08-29	2003-10-14	Kirin Beer Kabushiki Kaisha	Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene
EP0907726A4 (en)	1996-06-26	2001-11-07	Baylor College Medicine	CHROMOSOMAL REORDERING BY INSERTING TWO RECOMBINATION SUBSTRATES
ATE549918T1 (de)	1996-12-03	2012-04-15	Amgen Fremont Inc	Menschliche antikörper, die ausdrücklich menschliches tnf alpha binden
CN1203922A (zh)	1997-03-21	1999-01-06	三共株式会社	人源化抗人fas抗体
US20020062010A1 (en)	1997-05-02	2002-05-23	Genentech, Inc.	Method for making multispecific antibodies having heteromultimeric and common components
US6774279B2 (en)	1997-05-30	2004-08-10	Carnegie Institution Of Washington	Use of FLP recombinase in mice
US6147275A (en) *	1998-03-30	2000-11-14	Research Development Foundation	Corticotropin releasing factor receptor 1-deficient mice
GB9823930D0 (en)	1998-11-03	1998-12-30	Babraham Inst	Murine expression of human ig\ locus
RU10506U1 (ru)	1999-04-08	1999-08-16	Кривулин Виталий Николаевич	Ручной культиватор
EP1183344A4 (en)	1999-05-27	2003-06-25	Human Genome Sciences Inc	ADAM POLYNUCLEOTIDES AND POLYPEPTIDES
GB0001448D0 (en)	2000-01-21	2000-03-08	Novartis Ag	Organic compounds
US6596541B2 (en) *	2000-10-31	2003-07-22	Regeneron Pharmaceuticals, Inc.	Methods of modifying eukaryotic cells
US7105348B2 (en)	2000-10-31	2006-09-12	Regeneron Pharmaceuticals, Inc.	Methods of modifying eukaryotic cells
US6586251B2 (en)	2000-10-31	2003-07-01	Regeneron Pharmaceuticals, Inc.	Methods of modifying eukaryotic cells
DK1354034T3 (da)	2000-11-30	2008-03-25	Medarex Inc	Transgene transchromosomale gnavere til fremstilling af humane antistoffer
TWI255272B (en)	2000-12-06	2006-05-21	Guriq Basi	Humanized antibodies that recognize beta amyloid peptide
GB0031284D0 (en)	2000-12-21	2001-01-31	Ks Biomedix Ltd	High affinity antibodies
US7034134B2 (en)	2001-04-26	2006-04-25	Bristol-Myers Squibb Company	Polynucleotide encoding a novel metalloprotease highly expressed in the testis, MMP-29
ATE398172T1 (de)	2001-05-11	2008-07-15	Kirin Pharma Kk	Künstliches menschliches chromosom mit dem gen für die lambda-leichte kette menschlicher antikörper
US7473557B2 (en)	2001-06-06	2009-01-06	Regeneron Pharmaceuticals, Inc.	Method for targeting transcriptionally active loci
GB0115256D0 (en)	2001-06-21	2001-08-15	Babraham Inst	Mouse light chain locus
ATE477280T1 (de)	2001-06-28	2010-08-15	Domantis Ltd	Doppelspezifischer ligand und dessen verwendung
US20030108925A1 (en)	2001-10-05	2003-06-12	U.S. Epa	Genetic testing for male factor infertility
US20060199204A1 (en)	2001-10-05	2006-09-07	U.S. Epa	Genetic testing for male factor infertility
CA2847885C (en)	2001-11-30	2022-03-22	Amgen Fremont Inc.	Transgenic animals bearing human ig.lambda. light chain genes
US20030217171A1 (en)	2002-05-17	2003-11-20	Von Stuermer Wolfgang R.	Self-replicating and self-installing software apparatus
JP4099646B2 (ja)	2002-06-04	2008-06-11	株式会社安川電機	ボイスコイルモータ
ES2263984T3 (es)	2002-06-28	2006-12-16	Domantis Limited	Ligandos doble-especificos con una vida media serica aumentada.
ATE514717T1 (de)	2002-07-18	2011-07-15	Merus B V	Rekombinante produktion von antikörpermischungen
GB0228210D0 (en)	2002-12-03	2003-01-08	Babraham Inst	Single chain antibodies
EP1578801A2 (en)	2002-12-27	2005-09-28	Domantis Limited	Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
GB0230201D0 (en)	2002-12-27	2003-02-05	Domantis Ltd	Retargeting
GB0230203D0 (en)	2002-12-27	2003-02-05	Domantis Ltd	Fc fusion
GB2398784B (en)	2003-02-26	2005-07-27	Babraham Inst	Removal and modification of the immunoglobulin constant region gene cluster of a non-human mammal
US20100069614A1 (en)	2008-06-27	2010-03-18	Merus B.V.	Antibody producing non-human mammals
CN103205436B (zh)	2003-07-15	2016-05-25	人类多克隆治疗公司	人源化免疫球蛋白基因座
CN1605628A (zh)	2003-09-03	2005-04-13	中国疾病预防控制中心病毒病预防控制所	Cho细胞生产的人源抗甲肝病毒基因工程抗体
RU2251699C1 (ru)	2003-09-25	2005-05-10	Киселев Всеволод Иванович	Способ ранней и доклинической диагностики цервикального рака
PL1802193T3 (pl)	2004-10-19	2014-09-30	Regeneron Pharma	Sposób wytwarzania myszy homozygotycznej pod względem modyfikacji genetycznej
ES2318384T3 (es)	2005-06-30	2009-05-01	Borealis Technology Oy	Capa exterior de funda para cables de potencia o de comuniccion.
EP1991580A2 (en)	2006-01-25	2008-11-19	Erasmus University Medical Center Rotterdam	Generation of heavy-chain only antibodies in transgenic animals
GB0618345D0 (en)	2006-09-18	2006-10-25	Univ Erasmus	Binding molecules
GB0615327D0 (en)	2006-03-30	2006-09-13	Univ Edinburgh	Culture medium containing kinase inhibitors and uses thereof
EP2003960B1 (en)	2006-03-31	2015-06-10	E. R. Squibb & Sons, L.L.C.	Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
SI2041177T1 (sl)	2006-06-02	2012-03-30	Regeneron Pharma	Visoko afinitetna protitelesa za humani IL receptor
WO2008022391A1 (en)	2006-08-22	2008-02-28	G2 Inflammation Pty Ltd	Method for producing antibodies
HRP20140512T1 (hr)	2006-10-02	2014-07-04	Regeneron Pharmaceuticals, Inc.	Humana antitijela s visokim afinitetom za humani il-4 receptor
RU2448979C2 (ru)	2006-12-14	2012-04-27	Ридженерон Фармасьютикалз, Инк.	Антитела человека к дельта-подобному лиганду-4 человека
WO2009097006A2 (en)	2007-08-10	2009-08-06	Medarex, Inc.	Hco32 and hco27 and related examples
US7659842B2 (en)	2007-10-24	2010-02-09	Infineon Technologies Ag	Quantization error reduction in PWM full-MASH converters
CA2721231C (en)	2008-04-14	2015-10-06	Innovative Targeting Solutions Inc.	Sequence diversity generation in immunoglobulins
WO2009143472A2 (en)	2008-05-23	2009-11-26	Aliva Biopharmaceuticals, Inc.	Method of generating single vl domain antibodies in transgenic animals
AU2009298458B2 (en)	2008-09-30	2015-10-08	Ablexis, Llc	Non-human mammals for the production of chimeric antibodies
SG172176A1 (en)	2008-12-18	2011-07-28	Univ Erasmus Medical Ct	Non-human transgenic animals expressing humanised antibodies and use therof
GB0905023D0 (en)	2009-03-24	2009-05-06	Univ Erasmus Medical Ct	Binding molecules
NZ597481A (en) *	2009-07-08	2013-10-25	Kymab Ltd	Animal models and therapeutic molecules
US9445581B2 (en)	2012-03-28	2016-09-20	Kymab Limited	Animal models and therapeutic molecules
PT2509409T (pt)	2009-12-10	2016-09-29	Regeneron Pharma	Ratinhos que produzem anticorpos de cadeia pesada
US10143186B2 (en)	2010-02-08	2018-12-04	Regeneron Pharmaceuticals, Inc.	Common light chain mouse
US20120021409A1 (en)	2010-02-08	2012-01-26	Regeneron Pharmaceuticals, Inc.	Common Light Chain Mouse
CA2802591A1 (en)	2010-06-17	2011-12-22	Kymab Limited	Animal models and therapeutic molecules
MY195217A (en)	2010-06-22	2023-01-11	Regeneron Pharma	MICE Expressing An Immunoglobulin Hybrid Light Chain
MY172618A (en)	2010-08-02	2019-12-06	Regeneron Pharma	Mice that make binding proteins comprising vl domains
EP2638155A1 (en)	2010-11-08	2013-09-18	Kymab Limited	Cells & vertebrates for enhanced somatic hypermutation and class switch recombination
SI4067496T1 (sl)	2011-02-25	2023-07-31	Regeneron Pharmaceuticals, Inc.	Miši ADAM6
SG10201606158TA (en)	2011-08-05	2016-09-29	Regeneron Pharma	Humanized universal light chain mice
CN107056936B (zh)	2011-09-19	2021-09-03	科马布有限公司	免疫球蛋白基因多样性的操纵及多抗体治疗剂
EP2758534B1 (en)	2011-09-19	2020-04-29	Kymab Limited	Animals, repertoires & methods for the production of human antibodies
EP2761008A1 (en)	2011-09-26	2014-08-06	Kymab Limited	Chimaeric surrogate light chains (slc) comprising human vpreb
US10246509B2 (en)	2011-10-17	2019-04-02	Regeneron Pharmaceuticals, Inc.	Restricted immunoglobulin heavy chain mice
GB2496375A (en)	2011-10-28	2013-05-15	Kymab Ltd	A non-human assay vertebrate comprising human antibody loci and human epitope knock-in, and uses thereof
GB201122047D0 (en)	2011-12-21	2012-02-01	Kymab Ltd	Transgenic animals
US9253965B2 (en)	2012-03-28	2016-02-09	Kymab Limited	Animal models and therapeutic molecules
RU2664181C2 (ru)	2011-12-20	2018-08-15	Регенерон Фармасьютикалз, Инк.	Мыши с гуманизированной легкой цепью
RU2770016C2 (ru)	2012-02-01	2022-04-14	Регенерон Фармасьютикалз, Инк.	Гуманизированные грызуны, которые экспрессируют тяжелые цепи, содержащие домены vl
US9788534B2 (en)	2013-03-18	2017-10-17	Kymab Limited	Animal models and therapeutic molecules

2012
- 2012-12-17 RU RU2014127339A patent/RU2664181C2/ru active
- 2012-12-17 SG SG10201605675WA patent/SG10201605675WA/en unknown
- 2012-12-17 DK DK12809955.3T patent/DK2793567T3/en active
- 2012-12-17 JP JP2014549157A patent/JP6327750B2/ja active Active
- 2012-12-17 HR HRP20190897TT patent/HRP20190897T1/hr unknown
- 2012-12-17 ME MEP-2019-143A patent/ME03477B/me unknown
- 2012-12-17 LT LTEP12809955.3T patent/LT2793567T/lt unknown
- 2012-12-17 TR TR2019/03439T patent/TR201903439T4/tr unknown
- 2012-12-17 KR KR1020207026010A patent/KR102186822B1/ko active Active
- 2012-12-17 PL PL12809955T patent/PL2793567T3/pl unknown
- 2012-12-17 ES ES12809955T patent/ES2720186T3/es active Active
- 2012-12-17 MY MYPI2014001743A patent/MY173936A/en unknown
- 2012-12-17 RS RS20190641A patent/RS58761B1/sr unknown
- 2012-12-17 BR BR122021007339-2A patent/BR122021007339B1/pt active IP Right Grant
- 2012-12-17 BR BR112014015238-1A patent/BR112014015238B1/pt active IP Right Grant
- 2012-12-17 HU HUE12809955 patent/HUE044266T2/hu unknown
- 2012-12-17 US US13/716,238 patent/US9706759B2/en active Active
- 2012-12-17 KR KR1020147020454A patent/KR101924805B1/ko active Active
- 2012-12-17 MX MX2014007682A patent/MX356429B/es active IP Right Grant
- 2012-12-17 KR KR1020187034431A patent/KR102038974B1/ko active Active
- 2012-12-17 WO PCT/US2012/069981 patent/WO2013096142A1/en active Application Filing
- 2012-12-17 SM SM20190296T patent/SMT201900296T1/it unknown
- 2012-12-17 SI SI201231572T patent/SI2793567T1/sl unknown
- 2012-12-17 SG SG11201403326VA patent/SG11201403326VA/en unknown
- 2012-12-17 RU RU2018119366A patent/RU2761639C2/ru active
- 2012-12-17 CA CA2859408A patent/CA2859408C/en active Active
- 2012-12-17 PT PT12809955T patent/PT2793567T/pt unknown
- 2012-12-17 KR KR1020197031617A patent/KR102081657B1/ko active Active
- 2012-12-17 AU AU2012323987A patent/AU2012323987B2/en active Active
- 2012-12-17 IN IN6094DEN2014 patent/IN2014DN06094A/en unknown
- 2012-12-17 SG SG10201913164YA patent/SG10201913164YA/en unknown
- 2012-12-17 EP EP12809955.3A patent/EP2793567B1/en active Active
- 2012-12-17 KR KR1020207004911A patent/KR102156139B1/ko active Active
- 2012-12-17 EP EP19151471.0A patent/EP3527070A1/en active Pending
- 2012-12-17 MX MX2018006537A patent/MX378871B/es unknown
- 2012-12-17 CN CN201280070209.4A patent/CN104159444B/zh active Active
2013
- 2013-07-26 US US13/951,996 patent/US9622459B2/en active Active
2014
- 2014-06-16 IL IL233153A patent/IL233153B/en active IP Right Grant
- 2014-06-20 MX MX2021000298A patent/MX2021000298A/es unknown
2015
- 2015-10-07 AU AU2015238803A patent/AU2015238803B2/en active Active
2016
- 2016-12-13 JP JP2016240915A patent/JP2017046722A/ja not_active Withdrawn
2017
- 2017-05-02 US US15/585,023 patent/US10561124B2/en active Active
- 2017-10-26 AU AU2017251797A patent/AU2017251797B2/en active Active
2018
- 2018-04-09 IL IL258561A patent/IL258561B/en active IP Right Grant
- 2018-11-16 JP JP2018215387A patent/JP6728308B2/ja active Active
2019
- 2019-04-28 IL IL266268A patent/IL266268B/en active IP Right Grant
- 2019-05-17 CY CY20191100525T patent/CY1121638T1/el unknown
- 2019-12-30 US US16/729,798 patent/US11617357B2/en active Active
- 2019-12-30 US US16/729,852 patent/US11612151B2/en active Active
2020
- 2020-03-04 AU AU2020201596A patent/AU2020201596B2/en active Active
- 2020-07-01 JP JP2020113809A patent/JP7152447B2/ja active Active
2022
- 2022-08-24 AU AU2022221449A patent/AU2022221449A1/en not_active Abandoned
- 2022-09-29 JP JP2022156704A patent/JP7507823B2/ja active Active
2023
- 2023-02-15 US US18/110,276 patent/US20230337646A1/en active Pending
2024
- 2024-06-18 JP JP2024098071A patent/JP2024113207A/ja active Pending
2025
- 2025-04-17 AU AU2025202709A patent/AU2025202709A1/en active Pending

Also Published As

Publication number	Publication date
CN104159444B (zh)	2017-09-01
US11612151B2 (en)	2023-03-28
RU2664181C2 (ru)	2018-08-15
US20170332609A1 (en)	2017-11-23
MX2021000298A (es)	2022-06-08
JP2022180594A (ja)	2022-12-06
SMT201900296T1 (it)	2019-07-11
SG11201403326VA (en)	2014-07-30
US20200221675A1 (en)	2020-07-16
US9706759B2 (en)	2017-07-18
RU2018119366A3 (pl)	2021-10-06
KR102156139B1 (ko)	2020-09-15
KR20190124339A (ko)	2019-11-04
HUE044266T2 (hu)	2019-10-28
JP2017046722A (ja)	2017-03-09
AU2025202709A1 (en)	2025-05-08
PL2793567T3 (pl)	2019-09-30
RU2761639C2 (ru)	2021-12-13
EP2793567A1 (en)	2014-10-29
IL258561A (en)	2018-05-31
LT2793567T (lt)	2019-04-10
SG10201605675WA (en)	2016-09-29
HK1202772A1 (en)	2015-10-09
AU2022221449A1 (en)	2022-11-24
KR20180132938A (ko)	2018-12-12
US20140017228A1 (en)	2014-01-16
RS58761B1 (sr)	2019-06-28
AU2020201596B2 (en)	2022-05-26
AU2017251797B2 (en)	2019-12-05
IL233153A0 (en)	2014-07-31
IL266268A (en)	2019-06-30
KR20140116135A (ko)	2014-10-01
JP7507823B2 (ja)	2024-06-28
AU2015238803B2 (en)	2017-11-16
MX378871B (es)	2025-03-10
HRP20190897T1 (hr)	2019-09-20
ES2720186T3 (es)	2019-07-18
CA2859408C (en)	2020-06-16
KR102038974B1 (ko)	2019-10-31
BR112014015238B1 (pt)	2022-11-16
IN2014DN06094A (pl)	2015-08-14
AU2017251797A1 (en)	2017-11-16
RU2014127339A (ru)	2016-02-10
AU2012323987B2 (en)	2015-07-09
US11617357B2 (en)	2023-04-04
MY173936A (en)	2020-02-27
KR102081657B1 (ko)	2020-02-26
KR20200108113A (ko)	2020-09-16
JP2020168014A (ja)	2020-10-15
TR201903439T4 (tr)	2019-04-22
DK2793567T3 (en)	2019-04-15
IL233153B (en)	2018-04-30
IL266268B (en)	2020-05-31
AU2015238803A1 (en)	2015-10-29
AU2012323987A1 (en)	2013-07-04
JP2024113207A (ja)	2024-08-21
IL258561B (en)	2019-05-30
NZ627211A (en)	2016-03-31
CN104159444A (zh)	2014-11-19
WO2013096142A1 (en)	2013-06-27
JP6327750B2 (ja)	2018-05-23
AU2020201596A1 (en)	2020-03-19
BR122021007339B1 (pt)	2022-11-29
US10561124B2 (en)	2020-02-18
US9622459B2 (en)	2017-04-18
JP2019047806A (ja)	2019-03-28
KR102186822B1 (ko)	2020-12-04
US20200221676A1 (en)	2020-07-16
EP3527070A1 (en)	2019-08-21
BR112014015238A2 (pt)	2020-12-29
MX356429B (es)	2018-05-29
KR20200021552A (ko)	2020-02-28
ME03477B (me)	2020-01-20
MX2014007682A (es)	2015-05-11
EP2793567B1 (en)	2019-02-27
PT2793567T (pt)	2019-05-27
JP2015502177A (ja)	2015-01-22
CA2859408A1 (en)	2013-06-27
SI2793567T1 (sl)	2019-05-31
US20130160153A1 (en)	2013-06-20
RU2018119366A (ru)	2018-11-09
CY1121638T1 (el)	2020-07-31
KR101924805B1 (ko)	2018-12-04
JP6728308B2 (ja)	2020-07-22
US20230337646A1 (en)	2023-10-26
JP7152447B2 (ja)	2022-10-12